Samuel Desta Guma , Kang Song , Haiguo Sun , Lei Yang , Zhaoyin Zhou , Jin Suo , Emmanuel Mintah Bonku , Wei Zheng , Guanghui Tian , Xiangrui Jiang , Qiumeng Zhang , Yan Zhang , Jingshan Shen
{"title":"新型3CLpro抗SARS-CoV-2抑制剂硫酰胺连接螺吡咯烷衍生物的设计、合成和生物学评价","authors":"Samuel Desta Guma , Kang Song , Haiguo Sun , Lei Yang , Zhaoyin Zhou , Jin Suo , Emmanuel Mintah Bonku , Wei Zheng , Guanghui Tian , Xiangrui Jiang , Qiumeng Zhang , Yan Zhang , Jingshan Shen","doi":"10.1016/j.bmc.2025.118239","DOIUrl":null,"url":null,"abstract":"<div><div>A series of thioamide-linked spiropyrrolidine derivatives were synthesized and evaluated against SARS-CoV-2 3CL<sup>pro</sup>. Among these compounds, <strong>9g</strong> demonstrated remarkable inhibition of 3CL<sup>pro</sup> (IC<sub>50</sub> = 35 nM), surpassing the inhibitory potency of the approved antiviral drug nirmatrelvir (IC<sub>50</sub> = 54 nM). In cellular assays against HCoV-OC43 in Huh7 cells, <strong>9g</strong> exhibited significant antiviral efficacy (EC<sub>50</sub> = 0.52 μM) and low cytotoxicity (CC<sub>50</sub> > 10 μM). Furthermore, <strong>9g</strong> exhibited pharmacokinetic profiles comparable to that of nirmatrelvir, making it a promising candidate for further development.</div></div>","PeriodicalId":255,"journal":{"name":"Bioorganic & Medicinal Chemistry","volume":"128 ","pages":"Article 118239"},"PeriodicalIF":3.3000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV-2\",\"authors\":\"Samuel Desta Guma , Kang Song , Haiguo Sun , Lei Yang , Zhaoyin Zhou , Jin Suo , Emmanuel Mintah Bonku , Wei Zheng , Guanghui Tian , Xiangrui Jiang , Qiumeng Zhang , Yan Zhang , Jingshan Shen\",\"doi\":\"10.1016/j.bmc.2025.118239\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>A series of thioamide-linked spiropyrrolidine derivatives were synthesized and evaluated against SARS-CoV-2 3CL<sup>pro</sup>. Among these compounds, <strong>9g</strong> demonstrated remarkable inhibition of 3CL<sup>pro</sup> (IC<sub>50</sub> = 35 nM), surpassing the inhibitory potency of the approved antiviral drug nirmatrelvir (IC<sub>50</sub> = 54 nM). In cellular assays against HCoV-OC43 in Huh7 cells, <strong>9g</strong> exhibited significant antiviral efficacy (EC<sub>50</sub> = 0.52 μM) and low cytotoxicity (CC<sub>50</sub> > 10 μM). Furthermore, <strong>9g</strong> exhibited pharmacokinetic profiles comparable to that of nirmatrelvir, making it a promising candidate for further development.</div></div>\",\"PeriodicalId\":255,\"journal\":{\"name\":\"Bioorganic & Medicinal Chemistry\",\"volume\":\"128 \",\"pages\":\"Article 118239\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-05-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Bioorganic & Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0968089625001804\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0968089625001804","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Design, synthesis, and biological evaluation of thioamide-linked spiropyrrolidine derivatives as novel 3CLpro inhibitors against SARS-CoV-2
A series of thioamide-linked spiropyrrolidine derivatives were synthesized and evaluated against SARS-CoV-2 3CLpro. Among these compounds, 9g demonstrated remarkable inhibition of 3CLpro (IC50 = 35 nM), surpassing the inhibitory potency of the approved antiviral drug nirmatrelvir (IC50 = 54 nM). In cellular assays against HCoV-OC43 in Huh7 cells, 9g exhibited significant antiviral efficacy (EC50 = 0.52 μM) and low cytotoxicity (CC50 > 10 μM). Furthermore, 9g exhibited pharmacokinetic profiles comparable to that of nirmatrelvir, making it a promising candidate for further development.
期刊介绍:
Bioorganic & Medicinal Chemistry provides an international forum for the publication of full original research papers and critical reviews on molecular interactions in key biological targets such as receptors, channels, enzymes, nucleotides, lipids and saccharides.
The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. A special feature will be that colour illustrations will be reproduced at no charge to the author, provided that the Editor agrees that colour is essential to the information content of the illustration in question.